Dantrium and blood creatine phosphokinase increased Patient Reports February 13, 2012

Dantrium Side Effects Report #5213001-0
Dantrium side effect was reported by a Physician from UNITED STATES on Jan 05, 2007. Male patient, 44 years of age, weighting 300.0 lb, was diagnosed with neuroleptic malignant syndrome, hypertension, schizoaffective disorder and was treated with Dantrium. After drug was administered, patient experienced the following side effects: agitation, anoxic encephalopathy, apnoea, aspiration, blood creatine phosphokinase increased, brain damage, cardiac arrest , cardio-respiratory arrest. Dantrium dosage: 116 MG EVERY 6HR, IV NOS ; 50 MG TWICE DAILY ORAL. During the same period patient was treated with NORVASC, CLOZAPINE, ATENOLOL, CLONAZEPAM, GLIPIZIDE, BROMOCRIPTINE MESYLATE, INSULIN, GLUCOPHAGE. Patient died on 09/01/2006.

Dantrium Side Effects Report #4830981-3
Dantrium side effect was reported by a Physician from JAPAN on Oct 31, 2005. Female patient, 29 years of age, was diagnosed with neuroleptic malignant syndrome and was treated with Dantrium. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, condition aggravated. Dantrium dosage: 80 MG TWICE DAILY, IV NOS. During the same period patient was treated with FAMOTIDINE, CEFOTIAM HYDROCHLORIDE, VITAMEDIN CAPSULE, VISCORIN, FLAVITAN, PARLODEL, DIAZEPAM. Patient was hospitalized. Patient recovered.

Dantrium Side Effects Report #5066151-6
Dantrium side effect was reported by a Physician from JAPAN on July 10, 2006. Female patient, weighting 17.64 lb, was diagnosed with cerebral palsy and was treated with Dantrium. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, pyrexia. Dantrium dosage: unknown. Patient was hospitalized. Patient recovered.

Dantrium Side Effects Report #4875024-0
Dantrium side effect was reported by a Physician from JAPAN on Dec 28, 2005. Male patient, 80 years of age, was treated with Dantrium. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, pyrexia. Dantrium dosage: unknown. During the same period patient was treated with ANALGESICS. Patient was hospitalized. Patient recovered.


Dantrium Side Effects Report #5360783-3
Dantrium side effect was reported by a Pharmacist from JAPAN on June 06, 2007. Male patient, 28 years of age, was diagnosed with analgesic effect and was treated with Dantrium. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, body temperature increased, hyperhidrosis, muscle tightness, neuroleptic malignant syndrome, tonic convulsion, tremor. Dantrium dosage: 40 MG. During the same period patient was treated with VEGETAMIN A, GOODMIN, ROHYPNOL, TOLEDOMIN, LEXOTAN, PENTAZOCINE LACTATE, PENTAZOCINE LACTATE. Patient recovered.